Cytologic and immunocytochemical findings of anaplastic large cell lymphoma: Analysis of ten fine-needle aspiration specimens over a 9-year period

Cancer

Volumn 99, Issue 1, 2003, Pages 33-43

  Ng, Wai Kuen ^a   Ip, Philip ^b   Choy, Carolyn ^b   Collins, Robert J ^b  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

ALK; Anaplastic large cell lymphoma (ALCL); CD30; Cytology

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD30 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CELL NUCLEUS; CELL STRUCTURE; CLINICAL ARTICLE; CYTODIAGNOSIS; CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES;

EID: 0037465576     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10922     Document Type: Article

References (44)

1. Das DK. Value and limitations of fine-needle aspiration cytology in diagnosis and classification of lymphomas: a review. Diagn Cytopathol. 1999;21:240-249.
2. Saboorian MH, Ashfaq R. The use of fine needle aspiration biopsy in the evaluation of lymphadenopathy. Semin Diagn Pathol. 2001;18:110-123.
3. Frable WJ, Kardos TF. Fine needle aspiration biopsy. Application in the diagnosis of lymphoproliferative diseases. Am J Surg Pathol. 1988;12:62-72.
4. Chan JK. Tumors of the lymphoreticular system, including spleen and thymus. In: Fletcher CD, editor. Diagnostic histopathology of tumors. New York: Churchill Livingstone, 2000:1099-1315.
5. Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe ES. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:230-235.
6. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet. 1998;1:292-293.
7. Noorduyn LA, de Bruin PC, van Heerde P, van de Sandt MM, Ossenkoppele GJ, Meijer CJ. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas. J Clin Pathol. 1994;47:33-37.
8. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
9. Chan JK, Banks PM, Cleary ML, et al. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology. 1994;25:517-536.
10. Chan JK, Banks PM, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol. 1995;103:543-560.
11. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification - from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol. 2000;11(Suppl 1):3-10.
12. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol. 1993;17:859-868.
13. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology. 1990;16:383-391.
14. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinicopathological findings and outcome. Blood. 1999;93:2697-2706.
15. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913-3921.
16. Chan JK, Cheuk W, Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol. 2001;25:761-768.
17. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394-1404.
18. Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood. 1997;89:1483-1490.
19. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076-2084.
20. Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphoma") with a wide morphological spectrum. Am J Pathol. 1998;153:875-886.
21. Wlodarska I, De Wolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. Blood. 1998;92:2688-2695.
22. Vergier B, Beylot-Barry M, Pulford K, et al. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol. 1998;22:1192-1202.
23. Tani E, Lowhagen T, Nasiell K, Ost A, Skoog L. Fine needle aspiration cytology and immunocytochemistry of large cell lymphomas expressing the Ki-1 antigen. Acta Cytol. 1989;33:359-362.
24. Yazdi HM, Burns BF. Fine needle aspiration cytology of Ki-1-positive large-cell "anaplastic" lymphoma. Acta Cytol. 1991;35:306-310.
25. Akhtar M, Ali MA, Haider A, Antonius J, Hainau B, al Dayel F. Fine-needle aspiration biopsy of Ki-1-positive anaplastic large-cell lymphoma. Diagn Cytopathol. 1992;8:242-247.
26. Dusenbery D, Jones DB, Sapp KW, Lemons FM. Cytologic findings in the sarcomatoid variant of large cell anaplastic (Ki-1) lymphoma. A case report. Acta Cytol. 1993;37:508-514.
27. McCluggage WG, Anderson N, Herron B, Caughley L. Fine needle aspiration cytology, histology and immunohistochemistry of anaplastic large cell Ki-1-positive lymphoma. A report of three cases. Acta Cytol. 1996;40:779-785.
28. Zakowski MF, Feiner H, Finfer M, Thomas P, Wollner N, Filippa DA. Cytology of extranodal Ki-1 anaplastic large cell lymphoma. Diagn Cytopathol. 1996;14:155-161.
29. Papadimitriou JC, Abruzzo LV, Bourquin PM, Drachenberg CB. Correlation of light microscopic, immunocytochemical and ultrastructural cytomorphology of anaplastic large cell Ki-1 lymphoma, an activated lymphocyte phenotype. A case report. Acta Cytol. 1996;40:1283-1288.
30. Bizjak-Schwarzbartl M. Large cell anaplastic Ki-1+ non-Hodgkin's lymphoma vs. Hodgkin's disease in fine needle aspiration biopsy samples. Acta Cytol. 1997;41:351-356.
31. Sgrignoli A, Abati A. Cytologic diagnosis of anaplastic large cell lymphoma. Acta Cytol. 1997;41:1048-1052.
32. Jayaram G, Abdul Rahman N. Cytology of Ki-1-positive anaplastic large cell lymphoma. A report of two cases. Acta Cytol. 1997;41:1253-1260.
33. Liu K, Dodd LG, Osborne BM, Martinez S, Olatdioye BA, Madden JF. Diagnosis of anaplastic large-cell lymphoma, including multifocal osseous Ki-1 lymphoma, by fine-needle aspiration biopsy. Diagn Cytopathol. 1999;21:174-179.
34. Gatter KM, Rader A, Braziel RM. Fine-needle aspiration biopsy of anaplastic large cell lymphoma, small cell variant with prominent plasmacytoid features: case report. Diagn Cytopathol. 2002;26:113-116.
35. Foss HD, Anagnostopoulos I, Araujo I, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88:4005-4011.
36. Foss HD, Demel G, Anagnostopoulos I, Araujo I, Hummel M, Stein H. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma. Pathobiology. 1997;65:83-90.
37. Krenacs L, Wellmann A, Sorbara L, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of Tand null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood. 1997;89:980-989.
38. Akhtar M, al-Dayel F, Siegrist K, Ezzat A. Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma presenting as a testicular mass. Mod Pathol. 1996;9:812-815.
39. McCluggage WG, Walsh MY, Bharucha H. Anaplastic large cell malignant lymphoma with extensive eosinophilic or neutrophilic infiltration. Histopathology. 1998;32:110-115.
40. Mann KP, Hall B, Kamino H, Borowitz MJ, Ratech H. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol. 1995;19:407-416.
41. Weiss LM. Epstein-Barr virus and Hodgkin's disease. Curr Oncol Rep. 2000;2:199-204.
42. Agarwal S, Ramanathan U, Naresh KN. Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma. Hum Pathol. 2002;33:146-152.
43. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumors cells of embryonal carcinoma. Am J Pathol. 1988;133:446-450.
44. Copie-Bergman C, Wotherspoon AC, Norton AJ, Diss TC, Isaacson PG. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol. 1998;22:1386-1392.